Our services

A simplified and customized approach

Retrospective Collections

Although thousands of biospecimen sources exist around the world, getting access to the right samples for your research is a quest for the proverbial needle in the haystack.

Through our network of partnered academic biobanks, hospitals and clinical sites, Trans-Hit Bio provides access to any biospecimen type (biofluids, fresh or frozen tissue, FFPE, CSF, etc.) and any specific associated data (mutational status, treatment history, medical follow-up, etc.) in any disease indication.

Trans-Hit Bio simplifies the process of finding the right retrospective biospecimen.


Customized Prospective Collections

For studies requiring prospective or tailored sample collection, we set up and manage prospective studies at selected clinical sites that have proven superior recruitment capabilities and comply with best-practice standards.

For example, you can design longitudinal studies, unique sampling procedures, or collect matched biospecimens from the same subject (e.g. tissue and serum).

Prospective collection, a complex process made easy for you.



Customized services

Customization of Tissue Microarrays

We offer a range of services for customized TMA’s:

Procurement of TMAs
If you do not have your own blocks to build the TMA, we can source the tissues through our network of academic biobank partners according to your specifications.

  • Disease
  • Inclusion and exclusion criteria
  • Pathologist QC
  • Pathology data
  • Patient associated data
  • Pathologist QC


Preparation of TMAs
Whether you already have the FFPE blocks you need to build the TMA or are still looking to procure some. Trans-Hit Bio can:

  • Manage the shipping of your blocks to the TMA laboratory
  • Built the TMA according to your specifications
  • Manage the shipment of remaining tissue back to your laboratory



Fully Annotated Lung Cancer Tissue Microarrays

Trans-Hit Biomarker collaborates with an International Accredited and ISO 9001 Certified pathology laboratory recognized internationally for its tissue microarrays (TMA) and lung cancer expertise to offer you fully annotated lung cancer TMAs. The TMA’s are built from tissues of the highest quality, collected under stringent technical and ethical guidelines. A cohort of 500 Caucasian patients (stages I-IV) is available and includes matched normal adjacent tissues and cases of primary tumor and matched metastatic tissue. Pathology, clinical and biomarker data are available for each patient and include a follow-up clinical data of a minimum of 3 years.

Learn more